Pentadecapeptide BPC 157 accelerates tendon-to-bone healing in rats
Primary theme: Tissue repair
Rodent model showed accelerated tendon-to-bone healing markers with stable gastric pentadecapeptide administration.
Library
A curated index of peptide studies — from foundational pharmacology to recent preclinical work. Search by compound name, study topic, or use-case keyword like recovery, anxiety, or growth hormone.
32 studies
Primary theme: Tissue repair
Rodent model showed accelerated tendon-to-bone healing markers with stable gastric pentadecapeptide administration.
Primary theme: Cardiac regeneration
Investigation of Tβ4's role in epicardial activation and vascular regeneration following induced ischemia.
Primary theme: Muscle recovery
Tβ4 supports actin sequestration, cell migration, and angiogenesis associated with skeletal muscle repair in rodent models.
Primary theme: Cognition
Intranasal Semax administration produced rapid changes in neurotrophin gene expression linked to cognition.
Primary theme: Anxiolysis
Selank demonstrated anxiolytic effects comparable to benzodiazepines without sedative profile in elevated plus-maze tests.
Primary theme: GH-axis pharmacology
Characterization of ipamorelin as a pentapeptide GHRP with minimal effects on cortisol and prolactin in vitro.
Primary theme: GH-axis pharmacokinetics
DAC-modified GHRH analog produced sustained increases in GH and IGF-I in clinical pharmacokinetic study.
Primary theme: Skin & wound repair
Review of copper-tripeptide effects on collagen synthesis, antioxidant signaling, and fibroblast activity.
Primary theme: Cellular senescence
Tetrapeptide induced telomerase activity and telomere elongation in cultured human fibroblasts.
Primary theme: Metabolic / body composition
GHRH analog demonstrated significant VAT reduction over 26 weeks in placebo-controlled trial.
Primary theme: Sexual function
Melanocortin receptor agonist evaluated in two phase-3 trials for premenopausal HSDD.
Primary theme: Metabolic regulation
Mitochondrial-derived peptide shown to influence insulin sensitivity and AMPK signaling in murine models.
Primary theme: Adiposity / metabolism
Selective NNMT inhibitor reduced adipose tissue mass and improved metabolic markers in obese mice.
Primary theme: Sleep architecture
Early investigations of DSIP's role in sleep architecture and stress-axis regulation.
Primary theme: Cardioprotection
GHRP-class peptide demonstrated GH-independent cardioprotection in ischemia-reperfusion models.
Primary theme: Gut health & stress
Review of pentadecapeptide effects on gut mucosa integrity and stress-induced lesions in rodents.
Primary theme: Neuroprotection
Neuroprotective effects of Semax demonstrated in rodent middle cerebral artery occlusion models.
Primary theme: Anabolic signaling
Modified IGF-1 analog with reduced IGFBP affinity shows prolonged systemic activity in growth and protein-synthesis assays.
Primary theme: Lipolysis
C-terminal hGH fragment investigated for lipolytic activity independent of classical GH receptor effects.
Primary theme: GH-axis pharmacology
GHRP-2 produced robust dose-dependent GH release in clinical pharmacology studies.
Primary theme: GH-axis & appetite
Ghrelin receptor agonist with characteristic appetite-stimulating signature alongside GH release.
Primary theme: Reproductive endocrinology
Single-bolus Kp-10 produced rapid increases in LH and testosterone via hypothalamic GnRH neurons.
Primary theme: Immune modulation
Review of Tα1 effects on T-cell maturation and cytokine signaling in chronic infection and immunosuppression models.
Primary theme: Social behavior
Meta-analytic evidence for oxytocin effects on trust, emotion recognition, and prosocial behavior.
Primary theme: Adipose ablation
Proapoptotic peptidomimetic targeting prohibitin in adipose vasculature produced weight loss in nonhuman primates.
Primary theme: Cellular energetics
Review of NAD+ decline with age and effects of NAD-boosting interventions on mitochondrial function.
Primary theme: Weight management
Long-acting amylin analog showed dose-dependent weight reduction as monotherapy in overweight adults.
Primary theme: Weight management
GIP/GLP-1/glucagon triple agonist demonstrated up to ~24% body weight reduction at 48 weeks.
Primary theme: Weight management
GIP/GLP-1 co-agonist produced substantial weight loss and improved metabolic markers in 72-week trial.
Primary theme: Weight management
GLP-1 analog produced ~15% mean body weight reduction in 68-week placebo-controlled trial.
Primary theme: Anabolic / muscle growth
Gene-delivery follistatin increased muscle mass via myostatin pathway inhibition in murine models.
Primary theme: HPTA support
Review of hCG dosing strategies for preservation of intratesticular testosterone and fertility during exogenous androgen use.